前收市價 | 25.36 |
開市 | 25.32 |
買盤 | 24.90 x 2200 |
賣出價 | 26.25 x 900 |
今日波幅 | 24.87 - 25.56 |
52 週波幅 | 24.58 - 109.52 |
成交量 | |
平均成交量 | 467,700 |
市值 | 273.43M |
Beta 值 (5 年,每月) | 1.21 |
市盈率 (最近 12 個月) | 4.04 |
每股盈利 (最近 12 個月) | 6.19 |
業績公佈日 | 2024年8月05日 - 2024年8月09日 |
遠期股息及收益率 | 6.60 (26.40%) |
除息日 | 2023年9月18日 |
1 年預測目標價 | 25.00 |
As the S&P 500 races toward new highs, some investors see small-cap value stocks as the best bet for long-term growth amid growing concerns about index-based stock concentration. As mega-caps like Nvidia (NASDAQ:NVDA) disproportionately drive the S&P 500’s performance, the index becomes more vulnerable to fluctuations—a few missteps could significantly impact your entire portfolio. In contrast, small-cap value stocks offer distinct advantages. They are small and nimble enough to adapt to changin
Medifast, Inc. (NYSE:MED) Q1 2024 Earnings Call Transcript April 29, 2024 Medifast, Inc. misses on earnings expectations. Reported EPS is $0.66 EPS, expectations were $0.78. MED isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Greetings. Welcome to the Medifast First […]
Medifast's (MED) first-quarter results reflect challenges related to a decline in active earning OPTAVIA Coaches, lower coach productivity and soft sales volume.